4-Methyl-1H-benzo[d]imidazol-2-amine

Catalog No.: 
ACVQJO796
CAS No.: 
171082-91-0
Molecular Formula: 
C8H9N3
Molecular Weight: 
147.18
4-Methyl-1H-benzo[d]imidazol-2-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$117.00InquiryInquiry
1g95%$224.00InquiryInquiry
5g95%$833.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Methyl-1H-benzo[d]imidazol-2-amine
IUPAC Name4-methyl-1H-benzo[d]imidazol-2-amine
MDL No.MFCD13188622
Molecular FormulaC8H9N3
Molecular Weight147.18
SMILESCC1=CC=CC2=C1N=C(N)N2
InChI KeyJYYASXKOESRUKU-UHFFFAOYSA-N
Synonym1H-Benzimidazol-2-amine, 4-methyl- (9CI);4-methyl-1H-benzimidazol-2-amine(SALTDATA: HBr);4-Methyl-1H-benzo[d]iMidazol-2-aMine;4-Methyl-1H-benziMidazol-2-aMine;1H-Benzimidazol-2-amine, 7-methyl-;4-Methyl-1h-benzimidazol-2-amine hydrobromide
CAS No.171082-91-0
PubChem CID14933021

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACVQJO796 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVQJO796 route product structure diagram
    ACVQJO796171082-91-0
Inquiry

2. ACVQJO796 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVQJO796 route product structure diagram
    ACVQJO796171082-91-0
Inquiry

3. ACVQJO796 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVQJO796 route product structure diagram
    ACVQJO796171082-91-0
Inquiry

Comments (0)